CorAssist Cardiovascular Ltd.

CorAssist is a clinical stage medical device company developing innovative therapeutic products for treating Heart failure with preserve ejection fraction. The company's proprietary technology enables the first implantation of devices that directly improves cardiac diastolic function. CORolla®, is an elastic self-expanding internal spring-like device implanted inside the left ventricular, through a Transapical or percutaneous procedure. The device assists diastolic function by improving diastolic dynamics and filling performance, and does not require an external power source. ImCardia® , the company's first product, is an elastic self-expanding device that is attached to the external left ventricular surface, through a simple off pump procedure.

• Employees 1
• Founded 2003
• Annual Revenue $5000000
• Total Funding $5250000